Related Experiment Video
Updated: Oct 1, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement
Andrew M Goldsweig1, Suzanne J Baron2
1Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Abstract:
Prosthetic valve endocarditis (PVE) following transcatheter aortic valve replacement (TAVR) in low surgical risk patients is uncommon, occurring in 11 of 396 patients (2.8%) in the study by Medranda et al., but associated with high morbidity (6 of 11 with embolic strokes [55%]) and mortality (2 of 11 [18%]). As TAVR volumes increase, especially in low surgical risk patients, whose long-term outcomes are generally excellent, PVE will become an increasingly important concern. Future research is needed to identify optimal strategies for prevention, diagnosis, and treatment of PVE associated with TAVR.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Aortic Regurgitation I: Introduction
Mitral Stenosis III: Medical Management

